FilingSEC EDGAR6-K
Regentis Biomaterials Reports Surgeon Interest in GelrinC at ICRS Summit
· SEC accepted
StageMarketing
Filing content
The company reported strong interest from orthopedic surgeons in its cartilage regeneration product, GelrinC, during the ICRS Summit held in Portugal.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…